Parallel Advisors, LLC Corcept Therapeutics Inc Transaction History
Parallel Advisors, LLC
- $4.18 Billion
- Q3 2024
A detailed history of Parallel Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 3,813,724 shares of CORT stock, worth $196 Million. This represents 4.22% of its overall portfolio holdings.
Number of Shares
3,813,724
Previous 3,815,760
0.05%
Holding current value
$196 Million
Previous $124 Million
42.31%
% of portfolio
4.22%
Previous 3.2%
Shares
24 transactions
Others Institutions Holding CORT
# of Institutions
346Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$850 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$514 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$425 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$335 Million0.48% of portfolio
-
State Street Corp Boston, MA3.52MShares$181 Million0.01% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.51B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...